Abstract
Background: Open (OA), laparoscopic (LA), and percutaneous (PA) ablation are all important treatment modalities for small hepatocellular carcinoma (HCC), However, which treatment approach is (A) most clinically effective, (B) cost-efficient and (C) regionally most prevalent across the U.S has not been thoroughly examined.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
